Task: Answer the multiple-choice question.
Query: Which drug exhibits a 21.036% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a. CCC(=O)Nc1ccc(C2=Nn3c(nnc3C(C)C)SC2)cc1.Cl
b. CCSc1nnc(-c2ccccc2NC(=O)CC)c(=O)[nH]1
Answer: a. CCC(=O)Nc1ccc(C2=Nn3c(nnc3C(C)C)SC2)cc1.Cl
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(=O)Nc1ccc(C2=Nn3c(nnc3C(C)C)SC2)cc1.Cl
CCC(=O)Nc1ccc(C2=Nn3c(nnc3C(C)C)SC2)cc1.Cl
N-[4-(3-propan-2-yl-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazin-6-yl)phenyl]propanamide;hydrochloride